{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T07:22:13Z","timestamp":1696749733667},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1007\/s11912-000-0063-3","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T14:42:37Z","timestamp":1180708957000},"page":"434-437","source":"Crossref","is-referenced-by-count":2,"title":["Neurosurgical advances in the treatment of brain tumors"],"prefix":"10.1007","volume":"2","author":[{"given":"Jeffrey J.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/neuonc\/1.1.14","volume":"1","author":"TS Surawicz","year":"1999","unstructured":"Surawicz TS, McCarthy BJ, Kupelian V, et al.: Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990\u20131994. Neuro-oncology 1999, 1:14\u201325.","journal-title":"Neuro-oncology"},{"key":"63_CR2","first-page":"923","volume-title":"Brain Tumors: An Encyclopedic Approach","author":"R Sawaya","year":"1995","unstructured":"Sawaya R, Bindal RK: Metastatic brain tumors. In Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH, Laws EH, Jr. Edinburg: Churchill Livingstone; 1995:923\u2013946."},{"key":"63_CR3","first-page":"243","volume-title":"Cancer of the Nervous System","author":"WKA Yung","year":"1996","unstructured":"Yung WKA, Sawaya R, Curran WJ, Jr., Fuller GN: Intracranial metastatic central nervous system tumors. In Cancer of the Nervous System. Edited by Levin VA. New York: Churchill Livingstone; 1996:243\u2013258."},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00334670","volume":"85","author":"E Karamitopoulou","year":"1993","unstructured":"Karamitopoulou E, Perentes E, Diamantis I: p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol (Berl) 1993, 85:611\u2013616.","journal-title":"Acta Neuropathol (Berl)"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00006123-199805000-00054","volume":"42","author":"R Sawaya","year":"1998","unstructured":"Sawaya R, Hammoud M, Schoppa D, et al.: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal brain tumors. Neurosurgery 1998, 42:1044\u20131056.","journal-title":"Neurosurgery"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006118018770","volume":"42","author":"KR Hess","year":"1999","unstructured":"Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999, 42:227\u2013231.","journal-title":"J Neurooncol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006123-199608000-00001","volume":"39","author":"A Giese","year":"1996","unstructured":"Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 1996, 39:235\u2013250.","journal-title":"Neurosurgery"},{"key":"63_CR8","first-page":"480","volume-title":"The Gliomas","author":"WJ Curran Jr","year":"1999","unstructured":"Curran WJ Jr, Scott CB, Leibel SA: Issues in the use of conventional and altered fractionation radiation therapy for pediatric and adult gliomas. In The Gliomas. Edited by Berger MS, Wilson CB. Philadelphia: WB Saunders; 1999:480\u2013488."},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0959-8049(98)00146-4","volume":"34","author":"S Gunderson","year":"1998","unstructured":"Gunderson S, Lote K, Watne K: A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas. Eur J Cancer 1998, 34:1565\u20131569.","journal-title":"Eur J Cancer"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","volume":"17","author":"WKA Yung","year":"1999","unstructured":"Yung WKA, Prados MD, Yay-Tur R, et al.: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 1999, 17:2762\u20132771.","journal-title":"J Clin Oncol"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1634\/theoncologist.4-3-209","volume":"4","author":"NG Avgeropoulos","year":"1999","unstructured":"Avgeropoulos NG, Batchelor TT: New treatment strategies for maligant gliomas. Oncologist 1999, 4:209\u2013224.","journal-title":"Oncologist"},{"key":"63_CR12","first-page":"10","volume-title":"Pathology and Genetics of Tumours of the Nervous System","author":"WK Cavenee","year":"2000","unstructured":"Cavenee WK, Furnari FB, Nagane M, et al.: Diffusely infiltrating astrocytomas. In Pathology and Genetics of Tumours of the Nervous System. Edited by Kleihues P, Cavenee WK. Lyon: IARC Press, 2000:10\u201321. A succinct discussion of the genetic factors contributing to development and behavior of glioblastomas, anaplastic astrocytomas, and astrocytomas."},{"issue":"suppl","key":"63_CR13","first-page":"133","volume":"68","author":"B Pirotte","year":"1997","unstructured":"Pirotte B, Goldman S, David P, et al.: Stereotactic brain biopsy guided by positron emission tomagraphy (PET) with [F-18] fluorodeoxyglucose and [C-11] methionine. Acta Neurochir 1997, 68(suppl):133\u2013138.","journal-title":"Acta Neurochir"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1006138609201","volume":"42","author":"GH Barnett","year":"1999","unstructured":"Barnett GH: The role of image-guided surgical planning and resection of gliomas. J Neurooncol 1999, 42:247\u2013258. A summary of technology that has now become standard in maximizing the accuracy of surgery in primary tumors of the brain.","journal-title":"J Neurooncol"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3171\/jns.1999.90.3.0591","volume":"90","author":"JD McDonald","year":"1999","unstructured":"McDonald JD, Chong BW, Lewine JD, et al.: Integration of preoperative and intraoperative functional brain mapping in a frameless stereotactic environment for lesions near eloquent cortex. J Neurosurg 1999, 90:591\u2013598.","journal-title":"J Neurosurg"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000099903","volume":"68","author":"C Giorgi","year":"1997","unstructured":"Giorgi C, Casolino DS: Preliminary clinical experience with intraoperative stereotactic ultrasound imaging. Stereotact Funct Neurosurg 1997, 68:54\u201358.","journal-title":"Stereotact Funct Neurosurg"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00006123-199909000-00001","volume":"45","author":"PM Black","year":"1999","unstructured":"Black PM, Alexander E III, Martin C, et al.: Craniotomy for turmor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999, 45:423\u2013431. A demonstration that imaging technology can be used as real time to tumor resection in a safe and efficacious manner. Sixty cases done with MRI during surgery are summarized, with citations of advantanges for assessment of tumor resection and target shift with this device.","journal-title":"Neurosurgery"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1006163328765","volume":"42","author":"KP Vives","year":"1999","unstructured":"Vives KP, Piepmeier MJ: Complications and expected outcome of glioma surgery. J Neurooncol 1999, 42:289\u2013302.","journal-title":"J Neurooncol"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1006122122404","volume":"42","author":"PG Matz","year":"1999","unstructured":"Matz PG, Cobbs C, Berger MS: Intraoperative cortical mapping as a guide to the surgical resection of gliomas. J Neuro-oncol 1999, 42:233\u2013245.","journal-title":"J Neuro-oncol"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/jns.1999.90.1.0035","volume":"90","author":"MD Taylor","year":"1999","unstructured":"Taylor MD, Bernstein M: Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 1999, 90:35\u201341.","journal-title":"J Neurosurg"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, et al.: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: the polymer-brain tumor treatment group. Lancet 1995, 345:1008\u20131012. Proof of the principle behind interstitial chemotherapy is provided in this report from a rigorously executed phase III trial.","journal-title":"Lancet"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P, et al.: Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997, 41:44\u201349.","journal-title":"Neurosurgery"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717549809031385","volume":"5","author":"W Chen","year":"1998","unstructured":"Chen W, He J, Olson JJ, Lu R: Brain tissue reaction following intracerebral injection of free or liposomally encapsulated BSH. Drug Deliv 1998, 5:1\u201310.","journal-title":"Drug Deliv"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0360-3016(99)00244-8","volume":"45","author":"GM Videtic","year":"1999","unstructured":"Videtic GM, Gaspar LE, Zamorano L, et al.: Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Rad Oncol Biol Phys 1999, 45:687\u2013692. Although brachytherapy can be associated with toxicity, such as cerebral radiation necrosis, the authors note that subgroups of patients can be identified as most likely to benefit from this treatment.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0360-3016(98)00159-X","volume":"41","author":"NJ Laperriere","year":"1998","unstructured":"Laperriere NJ, Leung PM, McKenzie S, et al.: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998, 41:1005\u20131011.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1042-3680(18)30200-6","volume":"10","author":"E Alexander 3rd","year":"1999","unstructured":"Alexander E 3rd, Loeffler JS: The role of radiosurgery for glial neoplasms. Neurosurg Clin N Am 1999, 10:351\u2013358. Although focused radiation techniques have been considerably refined over the past half century, they still do not address the portion of tumor that infiltrates beyond the main body of the lesion.","journal-title":"Neurosurg Clin N Am"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s007010050276","volume":"141","author":"K Johannesen Watne","year":"1999","unstructured":"Johannesen Watne K, Lote K, et al.: Intracavitary fractionated balloon brachytherapy in glioblastoma. Acta Neurochir 1999, 141:127\u2013133.","journal-title":"Acta Neurochir"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0360-3016(98)00215-6","volume":"42","author":"JF Dempsey","year":"1998","unstructured":"Dempsey JF, Williams JA, Stubbs JB, et al.: Dosimetric properities of a novel brachytherapy balloon applicator for treatment of malignant brain tumor resection cavity margins. Int J Radiat Oncol Biol Phys 1998, 42:421\u2013429.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/nm1297-1354","volume":"3","author":"Z Ram","year":"1997","unstructured":"Ram Z, Culver KW, Oshiro EM, et al.: Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med 1997, 3:1354\u20131361. This paper, describing one possible method by which gene therapy can be delivered, demonstrates that it can be used safely with careful control. The authors also point out that gene therapy in and of itself will not be the final answer to primary malignant brain tumors.","journal-title":"Nat Med"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00006123-199711000-00005","volume":"41","author":"DW Laske","year":"1997","unstructured":"Laske DW, Muraszko KM, Oldfield EH, et al.: Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery 1997, 41:1039\u20131051.","journal-title":"Neurosurgery"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0360-3016(97)00915-2","volume":"40","author":"K Hopkins","year":"1998","unstructured":"Hopkins K, Chandler C, Eatough J, et al.: Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose. Int J Radiat Oncol Biol Phys 1998, 40:835\u2013844.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1200\/JCO.1998.16.6.2202","volume":"16","author":"DD Bigner","year":"1998","unstructured":"Bigner DD, Brown MT, Friedman AH, et al.: Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 1998, 16:2202\u20132212.","journal-title":"J Clin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-000-0063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-000-0063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-000-0063-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:48:59Z","timestamp":1587574139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-000-0063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11912-000-0063-3","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}